Selected References

• Andrejko KL, et al. 2019. The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systemic review. Travel Med Infect Dis. 27:20-26.
• 2020. Antimalarial recommendations. https://wwwnc.cdc.gov/travel/yellowbook/2020/preparing-international-travelers/yellow-fever-vaccine-and-malaria-prophylaxis-information-by-country
• 2018. Malaria and breastfeeding. https://www.cdc.gov/breastfeeding/breastfeeding-special-circumstances/maternal-or-infant-illnesses/malaria.html
• 2020. Pregnant Travelers. https://wwwnc.cdc.gov/travel/yellowbook/2020/family-travel/pregnant-travelers
• 2019. Treatment of malaria: Guidelines for Clinicians-Alternatives for pregnant women. https://www.cdc.gov/malaria/diagnosis_treatment/clinicians3.html
• 2011. Update: New Recommendations for Mefloquine Use in Pregnancy. https://www.cdc.gov/malaria/new_info/2011/mefloquine_pregnancy.html
• Edstein, M.D., et al. 1986. Excretion of chloroquine, dapsone and pyrimethamine in human milk. Br J Clin Pharmacol. 22(6):733-735.
• Edstein, M.D., et al. 1988. Excretion of mefloquine in human breast milk. Chemotherapy. 34(3):165-169.
• Fried M and Duffy PE. 2017. Malaria during pregnancy. Cold Spring Harb Perspect Med. 7(6):a025551.
• Gomes C, et al. 2016. Clinical and non-clinical safety of artemisinin derivatives in pregnancy. Reprod Toxicol. 65:194-203.
• Hart, C.W. and R.F. Naunton. 1964. The Ototoxicity of Chloroquine Phosphate. Arch Otolaryngol. 80:407-12.
• Moore KA, et al. 2017. Quantification of the association between malaria in pregnancy and stillbirth: a systemic review and meta-analysis. Lancet Glob Health. 5(11):e1101-e1112.
• Saito M, et al. 2018. Antimalarial drugs for treating and preventing malaria in pregnant and lactating women. Expert Opin Drug Saf. 17(11):1129-1144.
• Takem EN and D’Alessandro U. 2013. Malaria in pregnancy. Mediterr J Hematol Infect Dis. 5(1): e2013010.
• Ullberg, S., Lindquist, N.G. and Sjostrand, S.E. 1970. Accumulation of chorioretinotoxic drugs in the foetal eye. Nature. 227: 1257.

Selected References:

• Ban L, West J, Gibson JE, et al. First trimester exposure to anxiolytic and hypnotic drugs and the risks of major congenital anomalies: a United Kingdom population-based cohort study. PLoS ONE. 2014;9(6):e100996.
• Barry WS, et al. SM. 1987. Exposure to benzodiazepines in utero. Lancet 1:1436-37.
• Bellantuono C, Tofani S, Di sciascio G, Santone G. Benzodiazepine exposure in pregnancy and risk of major malformations: a critical overview. Gen Hosp Psychiatry. 2013;35(1):3-8.
• Brandlistuen RE, et al. 2017. Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study. PLoS ONE 12(7): e0181042.
• Calderon-Margalit R, et al. 2009. Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am J Obstet Gynecol. 201(6):579.e1-8.
• Czeizel AE. 1988. Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod Toxicol 1:183-88.
• Czeizel AE, Toth M 1998. Birth weight, gestational age and medications during pregnancy. Int J Obstet Gynaecol Obstet 60:245-49.
• Eros E, et al. 2002. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolam, and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol 101:147-54.
• Kargas GA et al 1985 Perinatal mortality due to interaction of diphenhydramine and temazepam. N Eng J Med 313:1417-18
• Laegreid L, et al.1992. The effect of benzodiazepines on the fetus and the newborn. Neuropediatrics 23:18-23.
• Laegreid L, et al.1992. Neurodevelopment in late infancy after prenatal exposure to benzodiazepines—a prospective study. Neuropediatrics 23:60-67.
• McAllister-Williams RH et al. 2017. British Association for Psychopharmacology consensus guidance on the use of psychotropic mediation preconception, in pregnancy and postpartum. J Psychopharmacol 31:519-52.
• McElhatton PR, 1994. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 8(6):461-75.
• Ornoy A, et al.1998. Is benzodiazepine use during pregnancy really teratogenic? Reprod Toxicol 12:511-5.
• Sanchis A, et al. 1991. Adverse effects of maternal lorazepam on neonates. DICP Ann Pharmacother 25(10):1137-38.
• Shiono PH, et al. 1984. Oral clefts and diazepam use during pregnancy. N Engl J Med 311:919-20.
• Weber LWD. 1985. Benzodiazepines in pregnancy—academical debate or teratogenic risk? Biol Res Pregnancy 6(4):151-67.
• Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatr Serv. 2002;53(1):39-49.
• Wikner BN, et al. 2007. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: maternal characteristics. Pharmcoepidemiol Drug Saf 16(9):988-994.
• Wikner BN, et al. 2007. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations Pharmacoepidemiol Drug Saf 16(11):1203-1210.